학술논문
Sequential administration of anti-complement component C5 eculizumab and type-2 anti-CD20 obinutuzumab for the treatment of early antibody-mediated rejection after kidney transplantation: A proof of concept
Document Type
Article
Author
Source
In Clinical Immunology July 2024 264
Subject
Language
ISSN
1521-6616